15.10.2018 | Correction
Correction to: a Phase 2 Study of 16α-[18F]-Fluoro-17β-Estradiol Positron Emission Tomography (FES-PET) as a Marker of Hormone Sensitivity in Metastatic Breast Cancer (MBC)
Erschienen in: Molecular Imaging and Biology | Ausgabe 1/2019
Einloggen, um Zugang zu erhalten